Cancer Suits Over Novartis Eczema Drug Remanded
A judge has remanded four cases alleging Novartis Pharmaceutical Corp.'s prescription eczema drug Elidel caused them to develop cancer, saying punitive damage claims aren't enough to keep a case in federal...To view the full article, register now.
Already a subscriber? Click here to view full article